Apyx Medical (APYX) vs Neuronetics (STIM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Neuronetics (STIM) has outperformed Apyx Medical (APYX) over the past year, losing 4.6% versus a loss of 40.0%. Over five years, STIM leads with a -69.7% price change compared with -83.4% for APYX. Neuronetics is the larger company by market cap ($120.6 million vs $101.1 million), about 1.2 times the size.
Apyx Medical converts more of its revenue into profit, with a net margin of -21.2% versus -26.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APYX | STIM |
|---|---|---|
| Share price | $2.40 | $1.25 |
| Market cap | $101.10M | $120.60M |
| 1-day change | +0.42% | +0.81% |
| YTD return | -31.43% | -9.42% |
| 1-year return | -40.00% | -4.58% |
| 5-year return | -83.40% | -69.66% |
| EPS (TTM) | $-0.19 | $-0.32 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $52.84M | $149.16M |
| Revenue growth (YoY) | +9.86% | +99.17% |
| Net income (latest FY) | $-11.21M | $-39.00M |
| Gross margin | 62.53% | 48.48% |
| Operating margin | -12.20% | -21.08% |
| Net margin | -21.22% | -26.15% |
| 52-week high | $5.08 | $3.44 |
| 52-week low | $2.25 | $0.80 |
| Distance from 52-week high | -52.76% | -63.66% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +170.83% | +380.00% |
| Average volume | 146.81K | 1.76M |
| Shares outstanding | 42.12M | 96.48M |
| Employees | 205 | 658 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- STIM has outperformed APYX by 35.4 percentage points over the past year.
- Neuronetics grew revenue faster in its latest fiscal year (+99.17% vs +9.86%).
About Apyx Medical
APYX stock →Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM).
Health Care · Medical/Dental Instruments · 205 employees
About Neuronetics
STIM stock →Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally.
Health Care · Medical/Dental Instruments · 658 employees
APYX vs STIM FAQ
Which is bigger, Apyx Medical or Neuronetics?
Neuronetics (STIM) is larger, with a market capitalization of $120.60M compared with $101.10M for Apyx Medical (APYX).
Which stock has performed better over the past year, APYX or STIM?
STIM returned -4.58% over the past 12 months, compared with -40.00% for APYX (price return, excluding dividends). Past performance does not predict future results.
Are Apyx Medical and Neuronetics in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.